Skip to content

Gross Profit at other companies

Eli Lilly logo
Eli LillyLLY
$16.22B+54.4%
Pfizer logo
PfizerPFE
$10.9B+0.3%
Merck & Co. logo
Merck & Co.MRK
$12.09B-0.2%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$2.59B+7.8%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$34.32M+80.1%
Mannkind logo
MannkindMNKD
$82.66M+10.8%

Other financials

Income statement

See full
Revenue$21.1M+1,572%
Operating income-$996.0K+96.1%
Net income-$1.0M+95.9%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$67.1M+6.7%
Total debt$57.7M-45.7%
Total equity$202.9M+64.9%
Total assets$268.8M-9.7%

Cash flow

See full
Operating cash flow-$14.7M+66.4%
CapEx--100%
Free cash flow-$17.2M+21.5%

Valuation

See full
Market cap$986.12M+262%
Enterprise value$976.73M+209%
P/S14.2×+5.4×

Profitability

See full
Gross margin99.5%+1.5pp
Operating margin-34.8%-16.8pp
Net margin-37.5%-18.1pp
FCF margin-578.5%-283pp

Returns & leverage

See full
Return on equity-16%-7.2pp
Debt / equity0.3×-0.6×
Current ratio18.8×+16.6×

Where this comes from

Calculated from Lexicon Pharmaceuticals’s reported figures.

The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lexicon Pharmaceuticals's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lexicon Pharmaceuticals's gross profit?
Lexicon Pharmaceuticals (LXRX) reported gross profit of $20.99M in Q1 2026.
How has Lexicon Pharmaceuticals's gross profit changed year-over-year?
Lexicon Pharmaceuticals's gross profit increased by 1604.1% year-over-year, from $1.23M to $20.99M.
What is the long-term trend for Lexicon Pharmaceuticals's gross profit?
Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's gross profit has grown at a 259.1% compound annual growth rate (CAGR), from $298K to $49.53M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.